Time | Program | Speaker | ||
---|---|---|---|---|
09:25-09:40 | 15' | VIP Tea Meeting | ||
09:40~10:10 | 30' | Opening Ceremony | ||
10:10~10:30 | 20' | Break | ||
[Global Expert Forum] Next-Generation Vaccine and Immunotherapy Technologies | ||||
10:30~12:00 | 90' | Emerging Viral Glycoproteins: From Viral Entry and Assembly to Vaccines and Antivirals |
Hector Aguilar-Carreno President, American Society of Virology / Professor of Virology, Cornell University College of Veterinary Medicine |
|
Development Status and Achievements in the Field of Regenerative Medicine | Hardy TS Kagimoto CEO of Healios | |||
AI-enabled Immunotherapy: RNA Vaccines and Drugs | Nam Jin Woo Professor of Life Science, Hanyang University |
|||
Public Private Partnership in Engaging Leading Industries and Capturing Economic Value | Peter Chang Principal Scientist, A*STAR (Agency for Science, Technology and Research) |
|||
The Way Forward in Preparing for a New Pandemic:
100 Days Mission |
Shingai Machingaidze International Pandemic Preparedness Secretariat (IPPS) Co-chair |
|||
12:00-13:30 | 90' | Lunch | ||
[Industry Expert Forum] Breakthroughs in Vaccine & Immunotherapy Companies | ||||
13:30~16:00 | 150' | Advancing Immunotherapies using Closed Modular GMP manufacturing of Cell and Gene Therapies | Soong Poh Loong Field Application Scientist, APJ, Cell and Gene Therapy, Life Science Solutions Group of Thermo Fisher Scientific |
|
Optimizing the Design of AI-enabled Vaccine Manufacturing Processes | Kim Hye Mi SK Bioscience Digital Innovation Division DX Team Lead | |||
Development of Biopharmaceuticals using Virus-like Particle Technologies | Kim Hong Jin CEO / POSVAX CO., LTD | |||
Strategic Approach for Building Smart Factories with AX(Artificial Intelligence Transformation) for Intelligent Autonomous Manufacturing in the Bio Industry |
Park Jung Soo Professor of College of Computing and Informatics, Sungkyunkwan University |
|||
The Present and Future of VaxCell-Bio in Advancing Cancer Immunotherapies | Shin Eui Cheol VAXCELL-BIO CO., LTD Head of Strategic Planning Headquarters | |||
16:00~16:20 | 20' | Break | ||
16:20~17:10 | 50' | Panel Discussion on Advancing Vaccines and Immunotherapy | ||
17:10~17:30 | 20' | Closing Ceremony |
Date : 2024.10.25(Fri) 09:30~11:45 | Location : Hwasun Bio-Medicine Industrial Complex(3 Institutions)
Participants : Approximately 45 pre-registrants (*First come, first served)
*The detailed schedule is subject to change and the final schedule will be notified on the 3rd week of Octoberonly those who registered.
The National Immunotherapy Innovation Center, supported by the Ministry of Science and ICT, Jeollanam-do, and Hwasun-gun, is a national project dedicated to building an immunotherapy platform for the development and commercialization of cancer immunotherapies. The center focuses on advancing core immunotherapy technologies and generating high added value through technology transfer and commercialization of its innovations.
PCMO is a public CDMO (Contract Development & Manufacturing Organization) specializing in vaccines, established and funded by the Ministry of Trade, Industry, and Energy to drive the global industrialization of South Korea's vaccine industry. The center's mission is to support the production of clinical trial vaccine prototypes, process development, and commercialization by establishing internationally standardized production facilities as a specialized vaccine CMO.
The Bio-Pharmaceutical Research Center at Jeonnam Bio Foundation has established facilities for the production of active pharmaceutical ingredients, non-clinical and clinical trial samples, provides services to support the development and industrialization of biopharmaceuticals, and is committed to building the infrastructure needed for biopharmaceutical development through a range of support for industrial activities, including research and development and prototype production for bio-pharmaceutical companies.
COPYRIGHT(C) 2024 by HIVIF. ALL RIGHTS RESERVED.